Loading…

Values of Sleep/Wake, Activity/Rest, Circadian Rhythms, and Fatigue Prior to Adjuvant Breast Cancer Chemotherapy

Abstract Fatigue is the most prevalent and distressing symptom experienced by patients receiving adjuvant chemotherapy for early stage breast cancer. Higher fatigue levels have been related to sleep maintenance problems and low daytime activity in patients who have received chemotherapy, but knowled...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pain and symptom management 2007-04, Vol.33 (4), p.398-409
Main Authors: Berger, Ann M., PhD, RN, AOCN, FAAN, Farr, Lynne A., PhD, Kuhn, Brett R., PhD, CBSM, Fischer, Patricia, BSN, RN, CCRC, Agrawal, Sangeeta, MS
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c695t-394e1602458c61bfd68ce9d9258f7f683fa8ecb7586d5423c6142741bc5543723
cites cdi_FETCH-LOGICAL-c695t-394e1602458c61bfd68ce9d9258f7f683fa8ecb7586d5423c6142741bc5543723
container_end_page 409
container_issue 4
container_start_page 398
container_title Journal of pain and symptom management
container_volume 33
creator Berger, Ann M., PhD, RN, AOCN, FAAN
Farr, Lynne A., PhD
Kuhn, Brett R., PhD, CBSM
Fischer, Patricia, BSN, RN, CCRC
Agrawal, Sangeeta, MS
description Abstract Fatigue is the most prevalent and distressing symptom experienced by patients receiving adjuvant chemotherapy for early stage breast cancer. Higher fatigue levels have been related to sleep maintenance problems and low daytime activity in patients who have received chemotherapy, but knowledge describing these relationships prior to chemotherapy is sparse. The Piper Integrated Fatigue Model© guided this study, which describes sleep/wake, activity/rest, circadian rhythms, and fatigue and how they interrelate in women with Stage I, II, or IIIA breast cancer during the 48 hours prior to the first adjuvant chemotherapy treatment. The present report describes these variables in 130 females, mean age = 51.4 years; the majority were married and employed. Subjective sleep was measured by the Pittsburgh Sleep Quality Index and fatigue was measured by the Piper Fatigue Scale. Wrist actigraphy was used to objectively measure sleep/wake, activity/rest, and circadian rhythms. Mean Pittsburgh Sleep Quality Index score was 6.73 ± 3.4, indicating poor sleep. Objective sleep/wake results were within normal limits established for healthy individuals, except for the number and length of night awakenings. Objective activity/rest results were within normal limits except for low mean daytime activity. Circadian rhythm mesor was 132.3 (24.6) and amplitude was 97.2 (22.8). Mean Piper Fatigue Scale score was 2.56 ± 2, with 72% reporting mild fatigue. There were significant relationships between subjective and objective sleep, but no consistent patterns. Higher total and subscale fatigue scores were correlated with most components of poorer subjective sleep quality ( r = 0.25–0.42, P ≤ 0.005).
doi_str_mv 10.1016/j.jpainsymman.2006.09.022
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1892632</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0885392407000371</els_id><sourcerecordid>70331345</sourcerecordid><originalsourceid>FETCH-LOGICAL-c695t-394e1602458c61bfd68ce9d9258f7f683fa8ecb7586d5423c6142741bc5543723</originalsourceid><addsrcrecordid>eNqNks1v0zAYhyMEYqXwLyBzAC5tasexnVwmlYgB0iTQxsfRcp03q7N8zXYq5b_HUSs2OAAnH_y8H_bviaJXBMcEE76p43pQpnNT26ouTjDmMc5jnCSPogXJBF1zRujjaIGzjK1pnqRn0TPnaowxo5w-jc6IoLkQmCyi4btqRnCor9B1AzBsfqhbWKGt9uZg_LS5AudXqDBWq9KoDl3tJ79v3QqprkQXypubEdAXa3qLfI-2ZT0eVOfROwvKeVSoToNFxR7a3u_BqmF6Hj2pVOPgxelcRt8u3n8tPq4vP3_4VGwv15rnzIetUyAcJynLNCe7quSZhrzME5ZVouIZrVQGeidYxkuWJjRAaSJSstOMpVQkdBmdH_sO466FUkPnrWrkYE2r7CR7ZeTvN53Zy5v-IEmWJ5zODd6eGtj-LnyRl61xGppGddCPTgqeUiJEmLaM3vydxJQSmrJ_gkxgJiifZ-dHUNveOQvVr70JlrMCspYPFJCzAhLnMigQal8-fPh95SnzALw-Acpp1VQ2hGTcPZdxkaaCBq44chBiOhiw0mkDIdDSWNBelr35r3XO_-iiG9OZMPgWJnB1P9oueCCJdInE8np2dlYWi6ArFYT-BOaK6qg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>57057362</pqid></control><display><type>article</type><title>Values of Sleep/Wake, Activity/Rest, Circadian Rhythms, and Fatigue Prior to Adjuvant Breast Cancer Chemotherapy</title><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>ScienceDirect Journals</source><creator>Berger, Ann M., PhD, RN, AOCN, FAAN ; Farr, Lynne A., PhD ; Kuhn, Brett R., PhD, CBSM ; Fischer, Patricia, BSN, RN, CCRC ; Agrawal, Sangeeta, MS</creator><creatorcontrib>Berger, Ann M., PhD, RN, AOCN, FAAN ; Farr, Lynne A., PhD ; Kuhn, Brett R., PhD, CBSM ; Fischer, Patricia, BSN, RN, CCRC ; Agrawal, Sangeeta, MS</creatorcontrib><description>Abstract Fatigue is the most prevalent and distressing symptom experienced by patients receiving adjuvant chemotherapy for early stage breast cancer. Higher fatigue levels have been related to sleep maintenance problems and low daytime activity in patients who have received chemotherapy, but knowledge describing these relationships prior to chemotherapy is sparse. The Piper Integrated Fatigue Model© guided this study, which describes sleep/wake, activity/rest, circadian rhythms, and fatigue and how they interrelate in women with Stage I, II, or IIIA breast cancer during the 48 hours prior to the first adjuvant chemotherapy treatment. The present report describes these variables in 130 females, mean age = 51.4 years; the majority were married and employed. Subjective sleep was measured by the Pittsburgh Sleep Quality Index and fatigue was measured by the Piper Fatigue Scale. Wrist actigraphy was used to objectively measure sleep/wake, activity/rest, and circadian rhythms. Mean Pittsburgh Sleep Quality Index score was 6.73 ± 3.4, indicating poor sleep. Objective sleep/wake results were within normal limits established for healthy individuals, except for the number and length of night awakenings. Objective activity/rest results were within normal limits except for low mean daytime activity. Circadian rhythm mesor was 132.3 (24.6) and amplitude was 97.2 (22.8). Mean Piper Fatigue Scale score was 2.56 ± 2, with 72% reporting mild fatigue. There were significant relationships between subjective and objective sleep, but no consistent patterns. Higher total and subscale fatigue scores were correlated with most components of poorer subjective sleep quality ( r = 0.25–0.42, P ≤ 0.005).</description><identifier>ISSN: 0885-3924</identifier><identifier>EISSN: 1873-6513</identifier><identifier>DOI: 10.1016/j.jpainsymman.2006.09.022</identifier><identifier>PMID: 17397701</identifier><identifier>CODEN: JSPME2</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>actigraph ; Actigraphy ; activity/rest ; Aged ; Anesthesia &amp; Perioperative Care ; Biological and medical sciences ; Breast cancer ; Breast Neoplasms - drug therapy ; Breast Neoplasms - physiopathology ; Chemotherapy ; circadian rhythm ; Circadian Rhythm - physiology ; Circadian rhythms ; Fatigue ; Fatigue - physiopathology ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Mammary gland diseases ; Medical sciences ; Middle Aged ; Motor Activity - physiology ; Pain Medicine ; Pharmacology. Drug treatments ; Rest - physiology ; Sleep - physiology ; Sleep/wake ; Tumors ; Wakefulness - physiology</subject><ispartof>Journal of pain and symptom management, 2007-04, Vol.33 (4), p.398-409</ispartof><rights>U.S. Cancer Pain Relief Committee</rights><rights>2007 U.S. Cancer Pain Relief Committee</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c695t-394e1602458c61bfd68ce9d9258f7f683fa8ecb7586d5423c6142741bc5543723</citedby><cites>FETCH-LOGICAL-c695t-394e1602458c61bfd68ce9d9258f7f683fa8ecb7586d5423c6142741bc5543723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925,31000</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=18674473$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17397701$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Berger, Ann M., PhD, RN, AOCN, FAAN</creatorcontrib><creatorcontrib>Farr, Lynne A., PhD</creatorcontrib><creatorcontrib>Kuhn, Brett R., PhD, CBSM</creatorcontrib><creatorcontrib>Fischer, Patricia, BSN, RN, CCRC</creatorcontrib><creatorcontrib>Agrawal, Sangeeta, MS</creatorcontrib><title>Values of Sleep/Wake, Activity/Rest, Circadian Rhythms, and Fatigue Prior to Adjuvant Breast Cancer Chemotherapy</title><title>Journal of pain and symptom management</title><addtitle>J Pain Symptom Manage</addtitle><description>Abstract Fatigue is the most prevalent and distressing symptom experienced by patients receiving adjuvant chemotherapy for early stage breast cancer. Higher fatigue levels have been related to sleep maintenance problems and low daytime activity in patients who have received chemotherapy, but knowledge describing these relationships prior to chemotherapy is sparse. The Piper Integrated Fatigue Model© guided this study, which describes sleep/wake, activity/rest, circadian rhythms, and fatigue and how they interrelate in women with Stage I, II, or IIIA breast cancer during the 48 hours prior to the first adjuvant chemotherapy treatment. The present report describes these variables in 130 females, mean age = 51.4 years; the majority were married and employed. Subjective sleep was measured by the Pittsburgh Sleep Quality Index and fatigue was measured by the Piper Fatigue Scale. Wrist actigraphy was used to objectively measure sleep/wake, activity/rest, and circadian rhythms. Mean Pittsburgh Sleep Quality Index score was 6.73 ± 3.4, indicating poor sleep. Objective sleep/wake results were within normal limits established for healthy individuals, except for the number and length of night awakenings. Objective activity/rest results were within normal limits except for low mean daytime activity. Circadian rhythm mesor was 132.3 (24.6) and amplitude was 97.2 (22.8). Mean Piper Fatigue Scale score was 2.56 ± 2, with 72% reporting mild fatigue. There were significant relationships between subjective and objective sleep, but no consistent patterns. Higher total and subscale fatigue scores were correlated with most components of poorer subjective sleep quality ( r = 0.25–0.42, P ≤ 0.005).</description><subject>actigraph</subject><subject>Actigraphy</subject><subject>activity/rest</subject><subject>Aged</subject><subject>Anesthesia &amp; Perioperative Care</subject><subject>Biological and medical sciences</subject><subject>Breast cancer</subject><subject>Breast Neoplasms - drug therapy</subject><subject>Breast Neoplasms - physiopathology</subject><subject>Chemotherapy</subject><subject>circadian rhythm</subject><subject>Circadian Rhythm - physiology</subject><subject>Circadian rhythms</subject><subject>Fatigue</subject><subject>Fatigue - physiopathology</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Mammary gland diseases</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Motor Activity - physiology</subject><subject>Pain Medicine</subject><subject>Pharmacology. Drug treatments</subject><subject>Rest - physiology</subject><subject>Sleep - physiology</subject><subject>Sleep/wake</subject><subject>Tumors</subject><subject>Wakefulness - physiology</subject><issn>0885-3924</issn><issn>1873-6513</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><recordid>eNqNks1v0zAYhyMEYqXwLyBzAC5tasexnVwmlYgB0iTQxsfRcp03q7N8zXYq5b_HUSs2OAAnH_y8H_bviaJXBMcEE76p43pQpnNT26ouTjDmMc5jnCSPogXJBF1zRujjaIGzjK1pnqRn0TPnaowxo5w-jc6IoLkQmCyi4btqRnCor9B1AzBsfqhbWKGt9uZg_LS5AudXqDBWq9KoDl3tJ79v3QqprkQXypubEdAXa3qLfI-2ZT0eVOfROwvKeVSoToNFxR7a3u_BqmF6Hj2pVOPgxelcRt8u3n8tPq4vP3_4VGwv15rnzIetUyAcJynLNCe7quSZhrzME5ZVouIZrVQGeidYxkuWJjRAaSJSstOMpVQkdBmdH_sO466FUkPnrWrkYE2r7CR7ZeTvN53Zy5v-IEmWJ5zODd6eGtj-LnyRl61xGppGddCPTgqeUiJEmLaM3vydxJQSmrJ_gkxgJiifZ-dHUNveOQvVr70JlrMCspYPFJCzAhLnMigQal8-fPh95SnzALw-Acpp1VQ2hGTcPZdxkaaCBq44chBiOhiw0mkDIdDSWNBelr35r3XO_-iiG9OZMPgWJnB1P9oueCCJdInE8np2dlYWi6ArFYT-BOaK6qg</recordid><startdate>20070401</startdate><enddate>20070401</enddate><creator>Berger, Ann M., PhD, RN, AOCN, FAAN</creator><creator>Farr, Lynne A., PhD</creator><creator>Kuhn, Brett R., PhD, CBSM</creator><creator>Fischer, Patricia, BSN, RN, CCRC</creator><creator>Agrawal, Sangeeta, MS</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>7X8</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>5PM</scope></search><sort><creationdate>20070401</creationdate><title>Values of Sleep/Wake, Activity/Rest, Circadian Rhythms, and Fatigue Prior to Adjuvant Breast Cancer Chemotherapy</title><author>Berger, Ann M., PhD, RN, AOCN, FAAN ; Farr, Lynne A., PhD ; Kuhn, Brett R., PhD, CBSM ; Fischer, Patricia, BSN, RN, CCRC ; Agrawal, Sangeeta, MS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c695t-394e1602458c61bfd68ce9d9258f7f683fa8ecb7586d5423c6142741bc5543723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>actigraph</topic><topic>Actigraphy</topic><topic>activity/rest</topic><topic>Aged</topic><topic>Anesthesia &amp; Perioperative Care</topic><topic>Biological and medical sciences</topic><topic>Breast cancer</topic><topic>Breast Neoplasms - drug therapy</topic><topic>Breast Neoplasms - physiopathology</topic><topic>Chemotherapy</topic><topic>circadian rhythm</topic><topic>Circadian Rhythm - physiology</topic><topic>Circadian rhythms</topic><topic>Fatigue</topic><topic>Fatigue - physiopathology</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Mammary gland diseases</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Motor Activity - physiology</topic><topic>Pain Medicine</topic><topic>Pharmacology. Drug treatments</topic><topic>Rest - physiology</topic><topic>Sleep - physiology</topic><topic>Sleep/wake</topic><topic>Tumors</topic><topic>Wakefulness - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berger, Ann M., PhD, RN, AOCN, FAAN</creatorcontrib><creatorcontrib>Farr, Lynne A., PhD</creatorcontrib><creatorcontrib>Kuhn, Brett R., PhD, CBSM</creatorcontrib><creatorcontrib>Fischer, Patricia, BSN, RN, CCRC</creatorcontrib><creatorcontrib>Agrawal, Sangeeta, MS</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>MEDLINE - Academic</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of pain and symptom management</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berger, Ann M., PhD, RN, AOCN, FAAN</au><au>Farr, Lynne A., PhD</au><au>Kuhn, Brett R., PhD, CBSM</au><au>Fischer, Patricia, BSN, RN, CCRC</au><au>Agrawal, Sangeeta, MS</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Values of Sleep/Wake, Activity/Rest, Circadian Rhythms, and Fatigue Prior to Adjuvant Breast Cancer Chemotherapy</atitle><jtitle>Journal of pain and symptom management</jtitle><addtitle>J Pain Symptom Manage</addtitle><date>2007-04-01</date><risdate>2007</risdate><volume>33</volume><issue>4</issue><spage>398</spage><epage>409</epage><pages>398-409</pages><issn>0885-3924</issn><eissn>1873-6513</eissn><coden>JSPME2</coden><abstract>Abstract Fatigue is the most prevalent and distressing symptom experienced by patients receiving adjuvant chemotherapy for early stage breast cancer. Higher fatigue levels have been related to sleep maintenance problems and low daytime activity in patients who have received chemotherapy, but knowledge describing these relationships prior to chemotherapy is sparse. The Piper Integrated Fatigue Model© guided this study, which describes sleep/wake, activity/rest, circadian rhythms, and fatigue and how they interrelate in women with Stage I, II, or IIIA breast cancer during the 48 hours prior to the first adjuvant chemotherapy treatment. The present report describes these variables in 130 females, mean age = 51.4 years; the majority were married and employed. Subjective sleep was measured by the Pittsburgh Sleep Quality Index and fatigue was measured by the Piper Fatigue Scale. Wrist actigraphy was used to objectively measure sleep/wake, activity/rest, and circadian rhythms. Mean Pittsburgh Sleep Quality Index score was 6.73 ± 3.4, indicating poor sleep. Objective sleep/wake results were within normal limits established for healthy individuals, except for the number and length of night awakenings. Objective activity/rest results were within normal limits except for low mean daytime activity. Circadian rhythm mesor was 132.3 (24.6) and amplitude was 97.2 (22.8). Mean Piper Fatigue Scale score was 2.56 ± 2, with 72% reporting mild fatigue. There were significant relationships between subjective and objective sleep, but no consistent patterns. Higher total and subscale fatigue scores were correlated with most components of poorer subjective sleep quality ( r = 0.25–0.42, P ≤ 0.005).</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>17397701</pmid><doi>10.1016/j.jpainsymman.2006.09.022</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0885-3924
ispartof Journal of pain and symptom management, 2007-04, Vol.33 (4), p.398-409
issn 0885-3924
1873-6513
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1892632
source Applied Social Sciences Index & Abstracts (ASSIA); ScienceDirect Journals
subjects actigraph
Actigraphy
activity/rest
Aged
Anesthesia & Perioperative Care
Biological and medical sciences
Breast cancer
Breast Neoplasms - drug therapy
Breast Neoplasms - physiopathology
Chemotherapy
circadian rhythm
Circadian Rhythm - physiology
Circadian rhythms
Fatigue
Fatigue - physiopathology
Female
Gynecology. Andrology. Obstetrics
Humans
Mammary gland diseases
Medical sciences
Middle Aged
Motor Activity - physiology
Pain Medicine
Pharmacology. Drug treatments
Rest - physiology
Sleep - physiology
Sleep/wake
Tumors
Wakefulness - physiology
title Values of Sleep/Wake, Activity/Rest, Circadian Rhythms, and Fatigue Prior to Adjuvant Breast Cancer Chemotherapy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T17%3A48%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Values%20of%20Sleep/Wake,%20Activity/Rest,%20Circadian%20Rhythms,%20and%20Fatigue%20Prior%20to%20Adjuvant%20Breast%20Cancer%20Chemotherapy&rft.jtitle=Journal%20of%20pain%20and%20symptom%20management&rft.au=Berger,%20Ann%20M.,%20PhD,%20RN,%20AOCN,%20FAAN&rft.date=2007-04-01&rft.volume=33&rft.issue=4&rft.spage=398&rft.epage=409&rft.pages=398-409&rft.issn=0885-3924&rft.eissn=1873-6513&rft.coden=JSPME2&rft_id=info:doi/10.1016/j.jpainsymman.2006.09.022&rft_dat=%3Cproquest_pubme%3E70331345%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c695t-394e1602458c61bfd68ce9d9258f7f683fa8ecb7586d5423c6142741bc5543723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=57057362&rft_id=info:pmid/17397701&rfr_iscdi=true